Literature DB >> 20513132

Heterozygous SOX9 mutations allowing for residual DNA-binding and transcriptional activation lead to the acampomelic variant of campomelic dysplasia.

Alex Staffler1, Markus Hammel, Mandy Wahlbuhl, Christoph Bidlingmaier, Andreas W Flemmer, Philipp Pagel, Thomas Nicolai, Michael Wegner, Andreas Holzinger.   

Abstract

Campomelic dysplasia is a malformation syndrome with multiple symptoms including characteristic shortness and bowing of the long bones (campomelia). CD, often lethal due to airway malformations, is caused by heterozygous mutations in SOX9, an SRY-related gene regulating testis and chondrocyte development including expression of many cartilage genes such as type II collagen. Male to female sex reversal occurs in the majority of affected individuals with an XY karyotype. A mild form without campomelia exists, in which sex-reversal may be also absent. We report here two novel SOX9 missense mutations in a male (c.495C>G; p.His165Gln) and a female (c.337A>G; p.Met113Val) within the DNA-binding domain leading to non-lethal acampomelic CD. Functional analyses of mutant proteins demonstrate residual DNA-binding and transactivation of SOX9-regulated genes. Combining our data and reports from the literature we postulate a genotype-phenotype correlation: SOX9 mutations allowing for residual function lead to a mild form of CD in which campomelia and sex reversal may be absent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513132     DOI: 10.1002/humu.21238

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

1.  Mild Campomelic Dysplasia: Report on a Case and Review.

Authors:  S Corbani; E Chouery; B Eid; N Jalkh; J Abou Ghoch; A Mégarbané
Journal:  Mol Syndromol       Date:  2011-01-10

2.  Acampomelic form of campomelic dysplasia with SOX9 missense mutation.

Authors:  Hariharan Gopakumar; Andrea Superti-Furga; Sheila Unger; Gerd Scherer; P K Rajiv; Sheela Nampoothiri
Journal:  Indian J Pediatr       Date:  2013-04-07       Impact factor: 1.967

3.  Clinical and molecular characterization of a Brazilian cohort of campomelic dysplasia patients, and identification of seven new SOX9 mutations.

Authors:  Eduardo P Mattos; Maria Teresa V Sanseverino; José Antônio A Magalhães; Júlio César L Leite; Temis Maria Félix; Luiz Alberto Todeschini; Denise P Cavalcanti; Lavinia Schüler-Faccini
Journal:  Genet Mol Biol       Date:  2014-03-17       Impact factor: 1.771

4.  A mutation creating an upstream initiation codon in the SOX9 5' UTR causes acampomelic campomelic dysplasia.

Authors:  Anna E von Bohlen; Johann Böhm; Ramona Pop; Diana S Johnson; John Tolmie; Ralf Stücker; Deborah Morris-Rosendahl; Gerd Scherer
Journal:  Mol Genet Genomic Med       Date:  2017-03-21       Impact factor: 2.183

5.  Testicular dysgenesis/regression without campomelic dysplasia in patients carrying missense mutations and upstream deletion of SOX9.

Authors:  Yuko Katoh-Fukui; Maki Igarashi; Keisuke Nagasaki; Reiko Horikawa; Toshiro Nagai; Takayoshi Tsuchiya; Erina Suzuki; Mami Miyado; Kenichiro Hata; Kazuhiko Nakabayashi; Keiko Hayashi; Yoichi Matsubara; Takashi Baba; Ken-Ichirou Morohashi; Arisa Igarashi; Tsutomu Ogata; Shuji Takada; Maki Fukami
Journal:  Mol Genet Genomic Med       Date:  2015-07-14       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.